Literature DB >> 14605927

Conventional cutting vs. internal anal sphincter-preserving seton for high trans-sphincteric fistula: a prospective randomized manometric and clinical trial.

A P Zbar1, J Ramesh, M Beer-Gabel, R Salazar, M Pescatori.   

Abstract

BACKGROUND: Cutting setons have been used in complicated perirectal sepsis with good effect, although there is a moderately high incidence of fecal leakage after their use. The aim of this study was to compare a modified cutting seton, which repaired the internal anal sphincter muscle and re-routed the seton through the intersphincteric space, with a conventional cutting seton.
METHODS: A total of 34 patients were randomized between 1998 and 2002. They were prospectively assessed by continence score and anorectal manometry, and for anal function, clinical sepsis and fistula recurrence.
RESULTS: There was no difference in postoperative continence score, incidence of recurrent fistula or healing time between groups after a mean follow-up of 12 months. Resting anal manometric pressures and vector volumes were consistently higher with the modified seton (although not statistically significant), as was the area under the inhibitory curve during elicitation of the rectoanal inhibitory reflex across the full sphincter length. ( p<0.05).
CONCLUSION: A larger prospective study of internal anal sphincter-preserving seton use in cryptogenic high transshincteric fistula-in-ano appears justified.

Entities:  

Mesh:

Year:  2003        PMID: 14605927     DOI: 10.1007/s10151-003-0016-6

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  13 in total

1.  Functional importance of the internal anal sphincter in fistula surgery: correspondence for the original article entitled "For many high anal fistulas, lay open is still a good option" by GK Atkin, J Martins, P Tozer, P Ranchod, RKS Phillips (2011) Tech Coloproctol 15:143-150.

Authors:  Andrew P Zbar
Journal:  Tech Coloproctol       Date:  2011-10-05       Impact factor: 3.781

Review 2.  Controversies in the treatment of common anal problems.

Authors:  Ismail Sagap; Feza-H Remzi
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

Review 3.  Revisiting an ancient treatment for transphincteric fistula-in-ano 'There is nothing new under the sun' Ecclesiastes 1v9.

Authors:  F Soliman; G Sturgeon; R Hargest
Journal:  J R Soc Med       Date:  2015-07-07       Impact factor: 5.344

Review 4.  Complex anal fistula remains a challenge for colorectal surgeon.

Authors:  F Cadeddu; F Salis; G Lisi; I Ciangola; G Milito
Journal:  Int J Colorectal Dis       Date:  2015-01-09       Impact factor: 2.571

5.  A drug-laden elastomer for surgical treatment of anal fistula.

Authors:  Hairui Li; Bin Jiang; Jun Yan; Zhonghua Yang; Yanni Chen; Weiping Zhang; Alex C Choy; Chi-Ying M Lee; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2011-12       Impact factor: 4.617

6.  Cryptoglandular anal fistulas.

Authors:  Andreas Ommer; Alexander Herold; Eugen Berg; Alois Fürst; Marco Sailer; Thomas Schiedeck
Journal:  Dtsch Arztebl Int       Date:  2011-10-21       Impact factor: 5.594

7.  For many high anal fistulas, lay open is still a good option.

Authors:  G K Atkin; J Martins; P Tozer; P Ranchod; R K S Phillips
Journal:  Tech Coloproctol       Date:  2011-03-23       Impact factor: 3.781

Review 8.  Systematic review and meta-analysis of surgical interventions for high cryptoglandular perianal fistula.

Authors:  K W A Göttgens; R R Smeets; L P S Stassen; G Beets; S O Breukink
Journal:  Int J Colorectal Dis       Date:  2014-12-10       Impact factor: 2.571

9.  Fistulotomy or seton in anal fistula: a decisional algorithm.

Authors:  Andrea Cariati
Journal:  Updates Surg       Date:  2013-06-02

10.  Surgery for fistula-in-ano in a specialist colorectal unit: a critical appraisal.

Authors:  Pierpaolo Sileri; Federica Cadeddu; Stefano D'Ugo; Luana Franceschilli; Giovanna Del Vecchio Blanco; Elisabetta De Luca; Emma Calabrese; Sara Mara Capperucci; Valeria Fiaschetti; Giovanni Milito; Achille Lucio Gaspari
Journal:  BMC Gastroenterol       Date:  2011-11-09       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.